Completed PHASE3 INTERVENTIONAL 2-arm NCT00532493

Cooperative Studies Program #563 - Prazosin and Combat Trauma PTSD (PACT)

CSP #563 - Prazosin and Combat Trauma PTSD (PACT)

Sponsor: VA Office of Research and Development

Updated 8 times since 2017 Last updated: Mar 30, 2018 Started: Jan 6, 2010 Primary completion: Feb 28, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00532493, this PHASE3 trial focuses on PTSD and Sleep Disorders and remains completed. Sponsored by VA Office of Research and Development, it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

May 2018 — Jun 2018 [monthly]

Completed PHASE3
Feb 2017 — May 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

VA Office of Research and Development

Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Columbia, United States , Decatur, United States , Durham, United States , Kansas City, United States , Loma Linda, United States , Long Beach, United States , Madison, United States , Miami, United States , New York, United States and 5 more locations